Related Experiment Video
Updated: Jul 4, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Combination statin-fibrate therapy: safety aspects
R Franssen1, M Vergeer, E S G Stroes
1Department of Vascular Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
Diabetes, Obesity & Metabolism
|June 4, 2008
Summary
Gemfibrozil increases statin toxicity, but fenofibrate does not. Fenofibrate offers a safer option for combining fibrates with statin therapy in high-risk patients.
Area of Science:
- Cardiology
- Pharmacology
- Endocrinology
Background:
- Patients with type 2 diabetes and metabolic syndrome face high cardiovascular risk despite statin therapy.
- Guidelines suggest adding fibrates to statins, but myopathy concerns limit this combination.
- Gemfibrozil poses a myopathy risk due to statin metabolism interference.
Purpose of the Study:
- To evaluate the safety and efficacy of fenofibrate in combination with statin therapy.
- To differentiate the safety profiles of different fibrates when co-administered with statins.
Main Methods:
- Review of existing evidence on fibrate-statin interactions.
- Pharmacokinetic and metabolic assessments of fenofibrate and gemfibrozil with statins.
Main Results:
- Gemfibrozil significantly elevates statin plasma concentrations, increasing myotoxicity risk.
- Fenofibrate does not adversely affect statin metabolism or pharmacokinetics.
- Fenofibrate combination therapy shows a reduced potential for statin-induced myotoxicity.
Conclusions:
- Fenofibrate is a safer alternative to gemfibrozil for combination with statins.
- The risk of myopathy with fibrate-statin therapy is not a class effect.
- Further data from the ACCORD study will clarify fenofibrate-simvastatin efficacy in type 2 diabetes.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:23Atherosclerosis IV: Nursing Management
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...